C10ORF78 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.749200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.495800E-01
Normal-vs-Stage2
6.277000E-01
Normal-vs-Stage3
7.209200E-01
Normal-vs-Stage4
5.202600E-01
Stage1-vs-Stage2
8.007800E-01
Stage1-vs-Stage3
7.756600E-01
Stage1-vs-Stage4
9.861200E-01
Stage2-vs-Stage3
8.814600E-01
Stage2-vs-Stage4
8.522600E-01
Stage3-vs-Stage4
7.897200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.112200E-01
Normal-vs-AfricanAmerican
4.985800E-01
Normal-vs-Asian
4.630000E-01
Caucasian-vs-AfricanAmerican
6.022800E-01
Caucasian-vs-Asian
3.936000E-01
AfricanAmerican-vs-Asian
9.241400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.538000E-01
Normal-vs-Female
7.004000E-01
Male-vs-Female
7.628600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.302000E-01
Normal-vs-Age(41-60Yrs)
5.855400E-01
Normal-vs-Age(61-80Yrs)
7.010800E-01
Normal-vs-Age(81-100Yrs)
4.574000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.999770E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.981200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.002600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.190600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.055000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.870400E-01
Normal-vs-Daily Drinker
6.396400E-01
Normal-vs-Weekly Drinker
6.395000E-01
Normal-vs-Occasional Drinker
4.432200E-01
Normal-vs-Social Drinker
8.852400E-01
Non Drinker-vs-Daily Drinker
9.946200E-01
Non Drinker-vs-Weekly Drinker
1.003750E-01
Non Drinker-vs-Occasional Drinker
7.825400E-01
Non Drinker-vs-Social Drinker
5.923000E-01
Daily Drinker-vs-Weekly Drinker
9.683800E-02
Daily Drinker-vs-Occasional Drinker
7.584000E-01
Daily Drinker-vs-Social Drinker
5.727000E-01
Weekly Drinker-vs-Occasional Drinker
4.009500E-02
Weekly Drinker-vs-Social Drinker
4.227800E-01
Occasional Drinker-vs-Social Drinker
3.774200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.646200E-01
Normal-vs-Grade 2
7.919900E-02
Normal-vs-Grade 3
5.042200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.027640E-04
Grade 1-vs-Grade 3
6.010700E-04
Grade 1-vs-Grade 4
2.646200E-01
Grade 2-vs-Grade 3
9.946400E-01
Grade 2-vs-Grade 4
7.919900E-02
Grade 3-vs-Grade 4
5.042200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.559400E-01
Normal-vs-NonDiabetic
6.564000E-01
Diabetic-vs-NonDiabetic
3.480000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.852800E-01
Normal-vs-NoPancreatitis
7.233400E-01
Pancreatitis-vs-NoPancreatitis
1.746990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.331800E-01
Normal-vs-N1
7.083600E-01
N0-vs-N1
4.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.652160E-01
Normal-vs-TP53-NonMutant
9.365000E-01
TP53-Mutant-vs-TP53-NonMutant
5.69189999577446E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
